Biotech tropicana,IncAU an the African Union System: Guiding Principles.
GUIDELINES.
Aboubaka YARI & Venus YARI
----------------
Affiliation:
Biotech tropicana,IncAU.
-----------------
Abstract:
The Biotech tropicana Systems are a biotech company dedicated to promoting, applying and developing biotechnologies adapted to the needs of the developing world. We operate a unit that focuses on innovations of biotechnologies aligned with development objectives of the African Union: Biotech tropicana, IncAU. Here, we discuss our guiding principles of our biotech business operations in Africa.
Keywords: Africa; Biotechnology; Innovation; Business; Development; Promotion; Guidelines; Guiding Principles.
Background:
For guidance of our biotech business in Africa, we relied on guidelines set forth by the High-Level African Panel on Modern Biotechnology. We analyze the guidelines to design our proprietary internal development principles that will promote the success of our biotechnology activities in Africa. At implementation we strictly apply our policies to protect our interests and avoid getting in conflict with the guidelines set forth by the authorities in the fields, particularly in activities that are executed under partnerships and collaborations. While the Biotech tropicana Systems shall not be involved in internal affairs of its partners, our partnership policies are designed to protect our interests.
Here, we discuss selected guiding principles as set by the High-Level African Panel on Modern Biotechnology in applying biotechnologies as a development tool in Africa.
Organization:
This paper is designed to comport
- selected abstracts from ‘Freedom to Innovate: Biotechnology in Africa’s Development’, a Report of the High-Level African Panel on Modern Biotechnology , followed by
- comments on proprietary internal operational principles of the Biotech tropicana Systems.
Abstract 1:
On Promotion of Biotechnology for development in Africa:
High-Level African Panel on Modern Biotechnology
Panel Members:
Calestous Juma
Ismail Serageldin
Co-Chairs
Amadou Tidiane • Ba Mpoko Bokanga • Abdallah Daar •
Cheikh Modibo Diarra • Tewolde Egziabher • Lydia Makhubu •
Dawn Mokhobo • Lewis Mughogho • Samuel Nzietchueng •
George Sarpong • Cyrie Sendashonga • Ahmed Shembesh
Panel Members
African Union • Union Africaine
New Partnership for Africa's Development
African Union • Union Africaine
New Partnership for Africa's Development
The African Union (AU)
The African Union (AU) was established following the 9 September 1999
Declaration (the Sirte Declaration) of the Heads of State and Government
of the Organisation of the African Unity (OAU).
Vision:
The AU is based on a common vision of a united and strong Africa and on the need to build a partnership between
- governments and all segments of
- civil society, in particular women, youth and
- the private sector,
in order to strengthen solidarity and cohesion amongst the peoples of Africa. As a continental organization it focuses on the promotion of peace, security and stability.
Comments 1:
Areas of interests of the Biotech tropicana Systems:
- The private sector, commercial activities in Biotech.
- Civil society, promotion activities in Biotech
- Governments, development activities in Biotech
The Biotech tropicana Systems are an international privately owned Biotech Company operating on a global scale. Programs of Biotech tropicana Systems are designed with flexibility to facilitate their adaptation to country specific conditions at implementation level. While operating from the private sector, we also develop promotion and development programs that are supportive of our commercial activities.
The Biotech tropicana Systems are strictly closed to foreign capital. All programs are funded with internal funds of Biotech tropicana Systems, since the foundation of the system in 2000. Policy 3. Biotech tropicana Systems.
The Biotech tropicana Systems are opened to partnerships and collaborations. The Biotech tropicana Systems are a knowledge driven biotech company that aligned with principles established at high levels of knowledge. We screen all candidate partners for ability to operate in a manner that would be consistent with our knowledge standards. Policy 4. Biotech tropicana Systems.
See also ownership policy 5.Biotech tropicana Systems.
More information is available:
More information is available:
- http://btsabic.ucoz.com/publ/ascd_african_specific_biotech_company_database/1-1-0-8 , African Specific Biotech Company Database.
- www.bitechtropicana.ucoz.com
Abstracts 2:
The New Partnership for Africa’s Development (NEPAD)
The New Partnership for Africa’s Development (NEPAD) is an AU affiliated
development programme that was adopted in 2001.
The objective of NEPAD is to stimulate Africa’s development by bridging existing gaps in
- agriculture,
- health,
- education,
- infrastructure,
- information and communication technology,
- environment,
- tourism,
- science and technology.
Comments 2:
Areas of interests of the Biotech tropicana Systems:
- agriculture (Biotech tropicana,IncFOOD), Incubation site: Dosso, Niger, African Union
- health, (Biotech tropicana,IncHEALTH), Incubation site: Kampala, Uganda, African Union
- education, (Biotech tropicana,IncEDUCATIONAL), Incubation site: Kandi, Benin, African Union
- infrastructure, (Tropicana General Technologies, Inc, Incubation site: In process.
- information and communication technology, (Biotech tropicana,IncFACILITATOR), Incubation site: In process.
- Environment, (Biotech tropicana,IncENVIRONMENT), Incubation site: In Process.
- science and technology, Biotech tropicana Systems, Incubation site: Kandi, Benin, African Union
Discussion:
While the Biotech tropicana Systems welcome comments and opinions by non panel members, at operational levels we strictly enforce our internal guidelines and guidelines set forth by the authorities in the fields. Our experiences demonstrate that failure to comply with guidelines is one the main factors that determine the failures of projects to achieve results in Africa.
In local projects, large amount of money is invested in big projects executed by large numbers of projects specialists to produce negative development gains.
Applying our internal guidelines of low capital input, multiple small projects executed by a low number of project specialists when combined with strict respect of the guidelines set by the authorities of the field produce net positive development gains.
The main problem we encounter in Africa is that when the locals violate guidelines in their big money projects, produce inevitable negative gains and kill their projects, they will start developing baseless arguments in their desperate attempts to ‘steal’ our positive development gains.
Our policy in the Biotech tropicana Systems is not waste our time and resources on baseless arguments. What they will encounter is our well organized security system to bust them out.
References:
[1] “Juma, C. and Serageldin, I. (Lead Authors) (2007). ‘Freedom to Innovate: Biotechnology in Africa’s Development’, A report of the High-Level African Panel on Modern Biotechnology. African Union (AU) and New Partnership for Africa’s Development (NEPAD). Addis Ababa and Pretoria.”
[2] [2] Biotech tropicana,IncAU at http://btau.ucoz.com/
| 
